Cargando…
Lack of Association of Variants Previously Associated with Anti-TNF Medication Response in Rheumatoid Arthritis Patients: Results from a Homogeneous Greek Population
Treatment strategies blocking tumor necrosis factor (anti-TNF) have proven very successful in patients with rheumatoid arthritis (RA), showing beneficial effects in approximately 50-60% of the patients. However, a significant subset of patients does not respond to anti-TNF agents, for reasons that a...
Autores principales: | Zervou, Maria I., Myrthianou, Efsevia, Flouri, Irene, Plant, Darren, Chlouverakis, Gregory, Castro-Giner, Francesc, Rapsomaniki, Panayiota, Barton, Anne, Boumpas, Dimitrios T., Sidiropoulos, Prodromos, Goulielmos, George N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769251/ https://www.ncbi.nlm.nih.gov/pubmed/24040234 http://dx.doi.org/10.1371/journal.pone.0074375 |
Ejemplares similares
-
Twenty Years of Targeted Treatment in Rheumatoid Arthritis in the Greek Databases: Achievements and Unmet Needs
por: Sidiropoulos, Prodromos, et al.
Publicado: (2019) -
Updated Greek Rheumatology Society Guidelines for the Management of Rheumatoid Arthritis
por: Vassilopoulos, Dimitrios, et al.
Publicado: (2020) -
Rheumatoid Arthritis-associated Interstitial Lung Disease in Greece: A Multicentre Epidemiological and Clinical Study
por: Karageorgas, Theofanis, et al.
Publicado: (2018) -
2018 Position Paper on Biosimilars of the Greek Rheumatology Society and Professional Association of Greek Rheumatologists
por: Patrikos, Dimos, et al.
Publicado: (2019) -
Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group
por: Genitsaridi, Irini, et al.
Publicado: (2020)